21 November 2017 in Virology Journal
Infection with the hepatitis E virus (HEV) can cause acute hepatitis in endemic areas in immune-competent hosts, as well as chronic infection in immune-compromised subjects in non-endemic areas. Most studies assessing HEV infection in HIV-infected populations have been performed in developed countries that are usually affected by HEV genotype 3. The objective of this study is to measure the prevalence and risk of acquiring HEV among HIV-infected individuals in Nepal. We prospectively evaluated 459 Human Immunodeficiency Virus (HIV)-positive individuals from Nepal, an endemic country for HEV, for seroprevalence of HEV and assessed risk factors associated with HEV infection. All individuals were on antiretroviral therapy and healthy blood donors were used as controls. We found a high prevalence of HEV IgG (39.4%) and HEV IgM (15.3%) in HIV-positive subjects when compared to healthy HIV-negative controls: 9.5% and 4.4%, respectively (OR: 6.17, 95% CI 4.42–8.61, p < 0.001 and OR: 3.7, 95% CI 2.35–5.92, p < 0.001, respectively). Individuals residing in the Kathmandu area showed a significantly higher HEV IgG seroprevalance compared to individuals residing outside of Kathmandu (76.8% vs 11.1%, OR: 30.33, 95% CI 18.02–51.04, p = 0.001). Mean CD4 counts, HIV viral load and presence of hepatitis B surface antigen correlated with higher HEV IgM rate, while presence of hepatitis C antibody correlated with higher rate of HEV IgG in serum. Overall, individuals with HEV IgM positivity had higher levels of alanine aminotransferase (ALT) than IgM negative subjects, suggesting active acute infection. However, no specific symptoms for hepatitis were identified. HIV-positive subjects living in Kathmandu are at higher risk of acquiring HEV infection as compared to the general population and to HIV-positive subjects living outside Kathmandu.
10 August 2016 in VirusDisease
The aim of this study was to detect the prevalence of hepatitis E virus (HEV) in healthy blood donors so as to decipher the maintenance of (HEV) reservoir if any. Five hundred and eighty-one blood samples along with clinical information were collected from central blood bank, Kathmandu between February and March 2014. Samples were tested for hepatitis B virus surface antigen, anti-hepatitis C virus antibodies, anti-hepatitis A virus IgM, HEV antigen, HEV viral load and anti-HEV antibodies (IgM and IgG) by ELISA. Only those samples positive with anti-HEV IgM were tested for HEV RNA by reverse transcriptase nested PCR. Age adjusted prevalence of IgM anti HEV and IgG anti HEV were 3.6 and 8.3 % respectively. No significant difference in Median ALT levels was noted between HEV RNA positive and negative subjects. Sequence analysis of HEV shows all genotype belongs to genotype 1a. Phylogenetic analysis shows the virus has homology of 95 % with strain from India and Nepal outbreak of April 2014. This study sheds light on how inter epidemic reservoirs can be maintained in healthy population with asymptomatic cases. This raises an important question regarding nature of HEV as well as its tendency to circulate in blind sight and also cause periodic outbreaks in endemic setting like Kathmandu.
19 August 2024 in Journal of Institute of Science and Technology
Dengue treatment and management is challenging during the epidemic especially among the risk groups and to mitigate the risks becomes even more complicated in absence of specific medicine and vaccines. Till date, there are no specific research endeavours in Nepal focusing on pregnant women with dengue and there is evident gap in research concerning the treatment of pregnant women due to overlapping clinical and hematological manifestations with physiological changes of gestation. The study comprises clinically diagnosed one dengue positive pregnant female, five female patients with dengue in Sukraraj Tropical and Infectious Disease Hospital (STIDH), Kathmandu and five healthy volunteers of same reproductive age. The study investigates six different inflammatory cytokines; IL-1β, IL-6, IL-8, IL-10, IL-12p70 and TNF levels in plasma and were quantified using Cytometric Bead Array. The Cytokine profiles and blood parameters were statistically analyzed using confidence intervals of 93.75% as permitted by sample size and visualized with box and whisker plot with a highlighted pregnant case. The study shows IL-6 and IL-10 levels are elevated on dengue cases as compared to healthy while TNF and IL-12p70 levels are elevated exceeding the upper limit of the acute dengue cases in the pregnant subject, underscoring heightened inflammatory activity during synchronous pregnancy and dengue infection. There were significant reductions in hemoglobin and leukocyte counts in the pregnant dengue case compared to non-pregnant. These findings suggest cytokine modulations occur during pregnancy and underscores the importance of these patterns provide insight into targeted therapeutic and diagnostic strategies to mitigate the risks for vulnerable population.